These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3598159)

  • 1. Immune effects of alpha-interferon in chronic liver disease.
    Peters M; Walling DM; Waggoner J; Avigan MI; Sjogren M; Hoofnagle JH
    J Hepatol; 1986; 3 Suppl 2():S283-9. PubMed ID: 3598159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of interferon-alpha treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B.
    Ishikawa T; Kakumu S; Yoshioka K; Kurokawa S; Kusakabe A; Tahara H; Hirofuji H; Kawabe M
    Liver; 1993 Apr; 13(2):95-101. PubMed ID: 8510492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis.
    Peters M; Walling DM; Kelly K; Davis GL; Waggoner JG; Hoofnagle JH
    J Immunol; 1986 Nov; 137(10):3147-52. PubMed ID: 3490513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological markers in patients with different forms of viral hepatitis B treated by "conventional" therapy or with HuIFN alpha.
    Stancek D; Janota S; Blaskovicová H; Hajnická V; Laktis K; Sudová J; Cvopová A; Klement C
    Acta Virol; 1990 Sep; 34(5):467-76. PubMed ID: 1981457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell-mediated cytolysis in patients with chronic hepatitis B virus infection.
    Alexander GJ; Nouri-Aria KT; Neuberger J; Bakhtiar M; Vogel W; Anderson MG; Magrin S; Eddleston AL; Williams R
    J Hepatol; 1986; 3 Suppl 2():S269-77. PubMed ID: 3110263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to the treatment of hepatitis B virus and delta-related liver disease.
    Thomas HC; Lever AM; Scully LJ; Pignatelli M
    Semin Liver Dis; 1986 Feb; 6(1):34-41. PubMed ID: 2424091
    [No Abstract]   [Full Text] [Related]  

  • 8. Membranous glomerulonephritis and chronic persistent hepatitis B in a child: treatment with recombinant interferon alfa.
    Jonas MM; Ragin L; Silva MO
    J Pediatr; 1991 Nov; 119(5):818-20. PubMed ID: 1941393
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon in chronic hepatitis B.
    Gregory PB
    Gastroenterology; 1986 Jan; 90(1):237-40. PubMed ID: 3940248
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of sizofiran, a polysaccharide, on interferon gamma, antibody production and lymphocyte proliferation specific for hepatitis B virus antigen in patients with chronic hepatitis B.
    Kakumu S; Ishikawa T; Wakita T; Yoshioka K; Ito Y; Shinagawa T
    Int J Immunopharmacol; 1991; 13(7):969-75. PubMed ID: 1761362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis B.
    Stancek D; Hajnická V; Blaskovicová H; Sudová J; Laktis K; Janota S; Jezek P
    Acta Virol; 1990 Sep; 34(5):457-66. PubMed ID: 1981456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B.
    Tsuji H; Murai K; Akagi K; Fujishima M
    J Clin Immunol; 1990 Jan; 10(1):38-44. PubMed ID: 2312667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of recombinant human alpha-interferon for chronic type B hepatitis.
    Dooley JS; Davis GL; Peters M; Waggoner JG; Goodman Z; Hoofnagle JH
    Gastroenterology; 1986 Jan; 90(1):150-7. PubMed ID: 3940241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol.
    Kanai K; Morioka S; Nakajima T; Ishii H; Tamakoshi K; Matsuda H; Matsumoto M; Mizushima N; Takehira Y
    Gastroenterol Jpn; 1988 Feb; 23(1):44-8. PubMed ID: 3350278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis B in children with recombinant alfa interferon. Different response according to age at infection.
    Bruguera M; Amat L; Garcia O; Lambruschini N; Carnicer J; Bergada A; Martin Orte E; Costa J; Sanchez-Tapias JM; Rodés J
    J Clin Gastroenterol; 1993 Dec; 17(4):296-9. PubMed ID: 8308214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J; Caselmann W; Eder M; Pape GR
    Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.